Delivery Order SPE2DB25D3020-SPE2DB25FWGLC
Award Date
3/14/25
Potential Completion Date
3/17/25
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,205.11 firm fixed-price delivery order contract covers the supply of XCOPRI 150 MG TABLET 30S, a pharmaceutical product, with a performance period through January 6, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,220.21 firm fixed-price delivery order contract, which has an ultimate completion date of December 13, 2024, is for the provision of XCOPRI 100 MG TABLET 30S, a medical product. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,504.11 firm fixed-price delivery order is for the supply of XCOPRI 200 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of March 4, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $7,121.59, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, which is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, covers the supply of XCOPRI 50 MG TABLET 30S, a pharmaceutical product. This IDC, valued at $999,999,999 and running through November 2026, serves as a primary vehicle for providing a...
This federal contract award, valued at $1,787.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medical product XCOPRI 100 MG TABLET 30S, with a completion date of March 17, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This federal contract award, valued at $1,203.80, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of XCOPRI 50 MG TABLET 30S, a pharmaceutical product, with a completion date of December 19, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, with a ceiling value of $1,206.40, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of...
This federal contract award, valued at $1,151.90, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of XCOPRI 100 MG TABLET 30S, a pharmaceutical product. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,585.56 Firm Fixed Price delivery order contract covers the supply of a medication product, XCOPRI 150 MG TABLET 30S. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,709.34 firm fixed-price contract is for the delivery of XCOPRI 100 MG TABLET 30S, a pharmaceutical product, through November 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary...